ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 79 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $14,445,000 | +16.2% | 854,745 | +12.8% | 0.00% | 0.0% |
| Q3 2016 | $12,430,000 | +16.5% | 757,473 | +7.5% | 0.00% | +50.0% |
| Q2 2016 | $10,670,000 | +25.7% | 704,737 | +20.0% | 0.00% | 0.0% |
| Q1 2016 | $8,491,000 | -38.7% | 587,187 | +20.0% | 0.00% | -33.3% |
| Q4 2015 | $13,862,000 | +220.3% | 489,489 | +89.3% | 0.00% | +200.0% |
| Q3 2015 | $4,328,000 | -37.5% | 258,561 | -2.1% | 0.00% | -50.0% |
| Q2 2015 | $6,928,000 | +400.6% | 264,231 | +234.0% | 0.00% | – |
| Q1 2015 | $1,384,000 | -0.1% | 79,120 | -0.8% | 0.00% | – |
| Q4 2014 | $1,385,000 | +16.9% | 79,737 | +25.2% | 0.00% | – |
| Q3 2014 | $1,185,000 | +0.9% | 63,665 | -0.9% | 0.00% | – |
| Q2 2014 | $1,175,000 | – | 64,272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 984,329 | $6,999,000 | 4.03% |
| Broadfin Capital, LLC | 2,469,894 | $17,561,000 | 3.63% |
| Healthcare Value Capital, LLC | 100,000 | $711,000 | 2.74% |
| ARMISTICE CAPITAL, LLC | 2,744,000 | $19,510,000 | 1.07% |
| DELTEC ASSET MANAGEMENT LLC | 536,836 | $3,817,000 | 0.84% |
| SECTORAL ASSET MANAGEMENT INC | 808,924 | $5,751,000 | 0.69% |
| Mosaic Family Wealth, LLC | 91,314 | $649,000 | 0.26% |
| Worth Venture Partners, LLC | 59,740 | $425,000 | 0.24% |
| EMERALD ADVISERS, LLC | 626,247 | $4,453,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 565,319 | $4,019,000 | 0.16% |